These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24065321)

  • 1. Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study.
    Seddon JA; Hesseling AC; Finlayson H; Fielding K; Cox H; Hughes J; Godfrey-Faussett P; Schaaf HS
    Clin Infect Dis; 2013 Dec; 57(12):1676-84. PubMed ID: 24065321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.
    Seddon JA; Hesseling AC; Marais BJ; Jordaan A; Victor T; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):928-33. PubMed ID: 22583610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Drug Resistance in Childhood Tuberculosis in Cape Town, South Africa.
    Schaaf HS; Garcia-Prats AJ; Draper HR; Rautenbach C; Bosch C; Demers AM; Hesseling AC; Walters E
    Pediatr Infect Dis J; 2020 Jul; 39(7):604-608. PubMed ID: 32520889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
    Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-Echevarría A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
    PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and Safety of Ofloxacin in Children with Drug-Resistant Tuberculosis.
    Garcia-Prats AJ; Draper HR; Thee S; Dooley KE; McIlleron HM; Seddon JA; Wiesner L; Castel S; Schaaf HS; Hesseling AC
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6073-9. PubMed ID: 26195507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP).
    Seddon JA; Garcia-Prats AJ; Purchase SE; Osman M; Demers AM; Hoddinott G; Crook AM; Owen-Powell E; Thomason MJ; Turkova A; Gibb DM; Fairlie L; Martinson N; Schaaf HS; Hesseling AC
    Trials; 2018 Dec; 19(1):693. PubMed ID: 30572905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of multidrug-resistant tuberculosis in Thailand.
    Maranetra KN
    Chemotherapy; 1996; 42 Suppl 3():10-5; discussion 30-3. PubMed ID: 8980862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa.
    Brust JCM; Shah NS; Mlisana K; Moodley P; Allana S; Campbell A; Johnson BA; Master I; Mthiyane T; Lachman S; Larkan LM; Ning Y; Malik A; Smith JP; Gandhi NR
    Clin Infect Dis; 2018 Apr; 66(8):1246-1253. PubMed ID: 29293906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.
    van der Laan LE; Garcia-Prats AJ; Schaaf HS; Tikiso T; Wiesner L; de Kock M; Winckler J; Norman J; McIlleron H; Denti P; Hesseling AC
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.
    Espinal MA; Kim SJ; Suarez PG; Kam KM; Khomenko AG; Migliori GB; Baéz J; Kochi A; Dye C; Raviglione MC
    JAMA; 2000 May; 283(19):2537-45. PubMed ID: 10815117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens.
    Yew WW; Chan CK; Chau CH; Tam CM; Leung CC; Wong PC; Lee J
    Chest; 2000 Mar; 117(3):744-51. PubMed ID: 10713001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study.
    von Gottberg A; Klugman KP; Cohen C; Wolter N; de Gouveia L; du Plessis M; Mpembe R; Quan V; Whitelaw A; Hoffmann R; Govender N; Meiring S; Smith AM; Schrag S;
    Lancet; 2008 Mar; 371(9618):1108-13. PubMed ID: 18359074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Culture-confirmed multidrug-resistant tuberculosis in children: clinical features, treatment, and outcome.
    Seddon JA; Hesseling AC; Willemse M; Donald PR; Schaaf HS
    Clin Infect Dis; 2012 Jan; 54(2):157-66. PubMed ID: 22052896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.
    Dawson R; Diacon AH; Everitt D; van Niekerk C; Donald PR; Burger DA; Schall R; Spigelman M; Conradie A; Eisenach K; Venter A; Ive P; Page-Shipp L; Variava E; Reither K; Ntinginya NE; Pym A; von Groote-Bidlingmaier F; Mendel CM
    Lancet; 2015 May; 385(9979):1738-1747. PubMed ID: 25795076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High treatment success in children treated for multidrug-resistant tuberculosis: an observational cohort study.
    Seddon JA; Hesseling AC; Godfrey-Faussett P; Schaaf HS
    Thorax; 2014 May; 69(5):458-64. PubMed ID: 24064441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Children exposed to multidrug-resistant tuberculosis at a home-based day care centre: a contact investigation.
    Garcia-Prats AJ; Zimri K; Mramba Z; Schaaf HS; Hesseling AC
    Int J Tuberc Lung Dis; 2014 Nov; 18(11):1292-8. PubMed ID: 25299860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study.
    Fairlie L; Beylis NC; Reubenson G; Moore DP; Madhi SA
    BMC Infect Dis; 2011 Jan; 11():28. PubMed ID: 21269475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study.
    Zhao Y; Fox T; Manning K; Stewart A; Tiffin N; Khomo N; Leslie J; Boulle A; Mudaly V; Kock Y; Meintjes G; Wasserman S
    Clin Infect Dis; 2019 Apr; 68(9):1522-1529. PubMed ID: 30165431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of drug resistance amongst HIV-exposed and -infected children in a tuberculosis prevention trial.
    Hesseling AC; Kim S; Madhi S; Nachman S; Schaaf HS; Violari A; Victor TC; McSherry G; Mitchell C; Cotton MF;
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):192-5. PubMed ID: 22236919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoniazid preventive therapy in HIV-infected children on antiretroviral therapy: a pilot study.
    Gray DM; Workman LJ; Lombard CJ; Jennings T; Innes S; Grobbelaar CJ; Cotton MF; Zar HJ
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):322-7. PubMed ID: 24670570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.